Data / Form D filings / Otonomy, Inc.
Otonomy, Inc.: Form D filings
Otonomy, Inc., a biotechnology company in San Diego, CA, filed 3 Form D notices with the SEC between 2010 and 2011. The latest, on June 2, 2011, reports $24.2 million sold of a $38.8 million offering to 13 investors.
Find out what Otonomy, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5626 OBERLIN DRIVE, SUITE 100, San Diego, CA, 92121
- Phone
- (858) 768-7823
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1493566
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2011 | Amendment | $38,844,352 | $24,214,701 | $14,629,651 | 13 | Aug 26, 2010 | sec.gov |
| Sep 3, 2010 | New notice | $38,644,354 | $10,037,465 | $28,606,889 | 10 | Aug 26, 2010 | sec.gov |
| Jun 9, 2010 | New notice | $26,000,000 | $10,567,046 | $15,432,954 | 3 | May 28, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Dovey | Director | |
| Peter Bisgaard | Director | |
| Gerald Wroblewski | Executive Officer | |
| John McKearn | Director | |
| David Weber | Executive Officer, Director | |
| Heather Preston | Director | |
| Carl LeBel | Executive Officer | |
| Jay Lichter | Director | |
| Jeffrey Harris | Director | |
| Paul Cayer | Executive Officer |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of May 30, 2011 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Otonomy, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.